Full name
NOLATO STARGARD SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
32.50.Z - Manufacture of medical and dental instruments and supplies
32.30.Z - Manufacture of sports goods
46.46.Z - Wholesale of pharmaceutical goods
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,2 | -0,9 | 0,8 | 191,4 |
Gross profit (loss) | -0,6 | -1,8 | -1 | 45,9 |
EBITDA | 0,9 | -0,2 | 1,7 | 1058,6 |
Short time liabilities | 2,1 | 3,7 | 12,4 | 236,8 |
Other operating costs | 0 | 0 | 0 | -30,1 |
Equity capital | 6,6 | 7 | 6 | -14,6 |
Operating profit (EBIT) | -0,3 | -0,9 | 0,8 | 188,7 |
Assets | 19,6 | 21,3 | 22,7 | 6,5 |
Net profit (loss) | -0,6 | -1,8 | -1 | 42 |
Cash | 3,4 | 2,7 | 4,2 | 58,5 |
Net income from sale | 19,6 | 21,1 | 27 | 28,2 |
Liabilities and provisions for liabilities | 12,9 | 14,3 | 16,7 | 16,8 |
Working assets | 7,8 | 8,4 | 9,8 | 17,4 |
Other income costs | 0 | 0 | 0 | -64 |
Depreciation | 1,2 | 0,7 | 0,9 | 36,7 |
% | % | % | p.p. | |
Profitability of capital | -8,5 | -25,1 | -17,1 | 8 |
Equity capital to total assets | 33,9 | 32,8 | 26,3 | -6,5 |
Gross profit margin | -3 | -8,7 | -3,7 | 5 |
EBITDA Margin | 4,6 | -0,8 | 6,3 | 7,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 38 | 64 | 168 | 104 |
Current financial liquidity indicator | 3.7755014896392822 | 2.2716145515441895 | 0.7920650839805603 | -1,5 |
Net dept to EBITDA | 7.32859992980957 | -47.848785400390625 | 4.956340789794922 | 52,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane